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Abstract
Background: According to previous reviews, there is no clear evidence on the effects of dairy
consumption on body composition and bone properties in pediatric populations. There is a need
for further assessment of existing ﬁndings and the methodologic quality of studies before
summarizing the evidence.
Objective: The aim of the study was to assess the quality, methodologies, and substantive
ﬁndings of randomized controlled trials (RCTs) that examined the effects of dairy consumption
on body size, body composition, and bone properties in children and adolescents.
Methods: After searching PubMed and Google Scholar up to December 2016, 15 RCTs were
retained and included in this systematic review for further analysis. The quality of the included
studies was assessed via the Jadad scale; detailed methodologic and statistical characteristics
were evaluated, and the main ﬁndings were summarized.
Results: The effects of dairy consumption were found to be signiﬁcant for bone structure and
nonsigniﬁcant for body size and composition. Eight of the 11 RCTs that assessed bone found
signiﬁcant effects (P , 0.05) for bone mineral content and bone mineral density (BMD), with an
average 8% increase in BMD after 16 mo of dairy consumption. Conversely, signiﬁcant effects
(P, 0.05) were found only in 2 of the 14 RCTs that focused on body size (i.e., height and weight)
and in only 1 of the 11 RCTs that focused on body composition (i.e., lean mass).
Conclusions: The systematic consumption of dairy products may beneﬁt bone structure and
development, but it does not appear to affect body composition or body size in children and
adolescents. On the basis of the Jadad scale, the methodologic quality of the 15 RCTs was rated
as good overall. However, there were methodologic disparities and limitations that may have led
to nonsigniﬁcant results, particularly for body size and composition. Future RCTs designed to
address these limitations are warranted. Curr Dev Nutr 2017;1:e001214.
Introduction
Over the years there has been an increased interest in the eﬀects of dairy on body composi-
tion and bone development in humans. The results of the 4 following reviews, however, were
inconclusive for body composition, possibly due to methodologic limitations of the included
studies related to, for example, study design, experimental power, or compliance. In the re-
view by Barr (1), which assessed 30 randomized controlled trials (RCTs) with the use of dairy
products or calcium supplementation as the dietary intervention, only 3 RCTs focused on
children (girls) and found nonsigniﬁcant eﬀects of dairy consumption on body composition.
Their nonsigniﬁcant ﬁndings were attributed to inappropriate study designs, inadequate ex-
perimental power, and the possible increase in energy intake with increased dairy consump-
tion. Huang and McCrory (2) reviewed 5 observational studies and 10 RCTs that examined
the eﬀects of dairy intake and calcium supplementation on body composition in children.
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Three of the 5 observational studies reported signiﬁcant eﬀects of
intakes of dairy, calcium, or both on body composition. However,
none of the 10 RCTs (3 RCTs used dairy products and 7 RCTs
used calcium supplementation) showed signiﬁcant eﬀects, mainly
due to dietary report problems, lack of compliance monitoring,
and the confounding eﬀects of other dietary variables (e.g., energy
intake). A later review by Lanou and Barnard (3) found similar non-
signiﬁcant eﬀects of dairy consumption on body composition. This
review assessed 49 RCTs, 18 of which were in children and adoles-
cents, with only 5 of them using dairy foods as opposed to calcium
supplements. Finally, a recent systematic review and meta-analysis
of 36 observational studies and 4 RCTs showed modest eﬀects of
dairy intake on body composition (adiposity) in adolescents but
not in children (4).
The existing evidence for the positive eﬀects of dairy consump-
tion on bone in children and adolescents is more conclusive, even
though many of the relevant studies are methodologically dispar-
ate. Early RCTs showed signiﬁcant positive eﬀects of dairy pro-
ducts (e.g., milk) on bone-related variables [e.g., bone mineral
density (BMD) and bone mineral content (BMC)] in pediatric
populations (e.g., 5–7). Similarly, the longitudinal study by Fiorito
et al. (8) found calcium intake (especially from dairy foods) to have
beneﬁcial eﬀects on BMC in young girls. However, the review by
Lanou et al. (9) proposed that the existing evidence does not sup-
port the nutritional guidelines that suggest increased calcium or
dairy intake for enhancing bone mineralization in children and ad-
olescents. Lanou et al. (9) assessed 58 studies (22 cross-sectional,
13 retrospective, 10 longitudinal, and 13 RCTs) that examined the
eﬀects of dairy product consumption or calcium supplementation
on bone health in children and young adults. Twelve of 13 RCTs
had a minimum of 1 y of treatment, and 9 RCTs examined the ef-
fects of calcium supplementation. Only 3 of these 12 RCTs exam-
ined the eﬀects of dairy products either in combination with
calcium supplements [in 1 RCT by Matkovic et al. (10)] or alone
[in 2 RCTs by Cadogan et al. (5) and Chan et al. (6), respectively].
Furthermore, 27 of 37 studies, which used dairy or dietary calcium
intake and managed to control for weight, pubertal status, and ex-
ercise in children and young adults, showed no relation between
dietary calcium or dairy intake and bone. As a result, the authors
suggested the revision of the pediatric recommendations on calcium
and dairy intake due to the marginal eﬀects on bone (9, 11). In con-
trast, a later meta-analysis found that the increased consumption of
dietary calcium, via dairy products or supplements with andwithout
vitamin D, signiﬁcantly increased total body and lumbar spine BMC
in children with low baseline calcium intake (12). From the 21 RCTs
assessed in thismeta-analysis, only 4 studies used dairy, mainlymilk.
As stated by Huncharek et al. (12), the heterogeneity of the partici-
pants’ diet and calcium intake (low, near normal, or normal intakes)
might have aﬀected the ﬁndings of this meta-analysis. The same
study design limitation may also apply to the ﬁndings and conclu-
sions of the previous reviews by Lanou et al. (9, 11).
As mentioned in previous relevant reviews (1, 13), there is a
need for assessing the methodologic quality of the studies before
summarizing the evidence. In fact, the use of only RCTs for assess-
ing whether an experimental treatment is eﬀective or not may be
more appropriate (14). Therefore, the purpose of this review was
to examine the potential impact of dairy consumption on body size
and composition and on bone in children and adolescents with the
exclusive use of RCTs. In addition, this review assesses the quality
of the methodologies and summarizes the ﬁndings of the included
RCTs.
Methods
Search and selection criteria—strategy
Two databases [PubMed (https://www.ncbi.nlm.nih.gov/pubmed)
and Google Scholar (https://scholar.google.ca/)] were electronically
searched for studies suitable for this review up to December 2016.
The search terms included diﬀerent combinations of relevant key
words, namely dairy (consumption), body composition, bone, chil-
dren, adolescents, and pediatric population. The inclusion criteria
were as follows: articles written in English; RCTs; studies in pediat-
ric populations (,18 y old), males or females, or both sexes; inter-
ventions that included dairy products; and studies with outcomes
relevant to anthropometric measurements (e.g., height, weight,
and BMI), body composition [e.g., lean body mass (LBM), fat mass
(FM)], and bonemeasurements [e.g., BMD, BMC, and bone turnover
markers (BTMs)].
First, the titles of all of the studies found in the databases were
read and their relevance to the topic of the review was assessed.
Then, the abstracts and the full texts of the relevant studies
were read in order to check whether all of the inclusion criteria
were met. Last, the references of the relevant studies as well as
of previous systematic reviews and meta-analyses were checked
to locate additional studies.
Data extraction and management
Each study that met all of the inclusion criteria was subjected to the
systematic extraction of a number of key design, methodologic, and
statistical characteristics (Tables 1 and 2). The methodologic and
statistical characteristics included the following: sample size estima-
tion and power calculation (yes or no; if yes, the percentage of
power), adjustment for confounding eﬀects (yes or no; if yes, the var-
iables or covariates), control group (yes or no), dropouts (number of
participants, percentage), calculation of eﬀect size and CIs (yes or
no), diet and exercise assessment (method of assessment), and
limitations and recommendations (stated or not; if stated, which
limitations and recommendations) (Table 1). The design-speciﬁc
characteristics were as follows: 1) sample size (n after dropout) and
participants’ sex (male or female), age (mean and range in years),
country, weight proﬁle (e.g., normal weight, overweight, or obese),
and health status (healthy or not healthy); 2) study duration (weeks,
months, or years); 3) intervention [diet (dairy or calcium intake) and
exercise (type, frequency, duration, and intensity)]; 4) measurements
and variables (assessment tool); and 5) main ﬁndings (anthropomet-
ric measurements, body composition, and bone properties) (Table 2).
Quality assessment: Jadad scale
The quality of the included studies was assessed via the Jadad et al.
(26) scale. This scale has been used extensively in previous system-
atic reviews in various clinical areas, such as in obesity (27–29), due
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to its eﬃciency in assessing the methodologic quality of RCTs (30).
The scale includes 7 items leading to a 5-point scoring system that
assesses the methodologic quality of RCTs according to criteria rel-
evant to randomization, blinding, and dropouts. Speciﬁcally, 5 ques-
tions are positively scored by adding 1 point each for the “yes”
answers or 0 for the “no” answers, whereas the other 2 questions
are negatively scored by either subtracting 1 point for a positive an-
swer or by giving 0 for a negative answer (scores of 21 and 22 in-
dicate bad quality, scores of 0 and 1 indicate poor quality, scores of 2
and 3 indicate good quality, a score of 4 indicates very good quality,
and a score of 5 indicates excellent quality).
Included and excluded studies
A total of 15 studies met all of the inclusion criteria and were in-
cluded in this systematic review (Tables 1 and 2). Studies that did
not meet all of the inclusion criteria were excluded from further
analysis, such as the study by Bonjour et al. (31), in which partici-
pants were given a variety of other calcium-enriched foods (e.g.,
cakes, biscuits) along with dairy. Another example of an excluded
study was a study by Matkovic et al. (32), in which the study design
for examining the eﬀects of dairy consumption was not suitable
(2 designs were used in this study: an observational design for the
assessment of the eﬀects of a high-calcium diet with dairy, whereas
an RCT was used for the eﬀects of calcium supplements).
Results
Assessing the quality of the included studies (Jadad scale)
Most of the included studies were rated as good quality. Eight stud-
ies (6, 15–19, 22, 24) had a score of 2, and 5 studies (5, 7, 10, 21, 25)
had a score of 3. Only 2 studies (20, 23) had a score of 1, which in-
dicates poorer quality. However, it was previously shown in one sys-
tematic review (28) that the methodologic quality of studies can be
underestimated by 1–2 points with the use of the Jadad scale. Spe-
ciﬁcally, items 3 and 4 of this scale refer to blinding, which is not al-
ways applicable to the type of research, which assesses nutritional
and exercise interventions. Overall, the design quality of the 15 in-
cluded RCTs was assessed as satisfactory for the purpose of this
review.
Methodologic and statistical characteristics
The methodologic and statistical characteristics of the included
studies are summarized in Table 1. Power analyses to estimate sam-
ple size were performed in 7 studies. Speciﬁcally, 4 studies (10, 16, 17,
22) used a power of 80%, 2 studies (7, 25) used a power of 90%, and
1 study (21) used a power of 95%. A control group was implemented
in all of the studies except for that of St.-Onge et al. (24). Fourteen
of the 15 reviewed studies reported dropouts. The percentage
of dropouts was, on average, 13.3%, and ranged between 2.4%
(5) and 32.1% (23).
Adjustments for confounding factors [puberty, age, sex, body
and bone size, baseline weight, energy, protein and calcium in-
takes, and physical activity (PA)] were made in 7 studies (5, 15,
16, 18, 22, 24, 25). Eﬀect size was not estimated or presented in
any of the 15 studies, and CIs were reported in 4 studies (5, 18,TA
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19, 25). Dietary intake was assessed with food records (3-, 7-, or
9-d; 2–9 times during the study) in 10 studies (5–7, 10, 15, 16, 18, 20,
21, 25). In addition, 24-h, 3-and 7-d recalls were used in 3 studies
(19, 23, 24), an FFQ for nutritional or calcium intake was used in 5
studies (6, 7, 17, 22, 23), and a daily record of dairy product con-
sumption was used in 6 studies (7, 15, 17–20). Eight of the 15 in-
cluded studies (6, 7, 15, 17–20, 23) used more than one nutritional
assessment tool [e.g., FFQ and 24-h recalls in 1 study (23)]. PA
was assessed in 11 of the 15 included studies (5–7, 15, 16, 18, 19, 21,
23–25) mainly via questionnaires [only one study used accelerome-
ters (16)].
Methodologic limitations were stated in 5 studies (15, 16, 21, 22,
24). The main limitations were convenient and too-small sample
sizes, short study duration, recall bias on food records and PA
questionnaires, reliance on self-report for dietary assessment,
and questionnaire-based estimation of energy assessment. Recom-
mendations for future research were stated in 5 studies (10, 16, 22,
24, 25). The recommendations included larger sample sizes;
matching of participants for skeletal age, bone mass, and calcium
intake; use of participants with calcium deﬁciency; increasing cal-
cium intake; and use of energy-reduced diets.
Participant characteristics
The ﬁnal samples sizes (n, after dropouts) ranged from 28 to 698
participants (mean n = 135). Ten studies used ,100 participants
and 5 studies used 123–698 participants. In total, 2032 children
and adolescents participated in the 15 studies included in this review.
The sample comprised females only in 7 studies (n = 1157), males
only in one study (n = 28), and both sexes in 7 studies (n = 857).
The age of the participants ranged from 4.8 to 17 y, with more than
half of the studies (8 studies) including participants aged #10 y old.
Participants were described as overweight or obese in 4 studies (16,
21, 22, 24) and of normal weight in one study (15). In the remaining
10 studies, no data were reported on participants’ weight classiﬁ-
cation; however, on the basis of the reported anthropometric data,
these participants, on average, can be considered to be of normal
weight. With the exception of one study (23), the health status of
the participants was not stated; participants were reported as
healthy in the other 14 included studies. The studies were under-
taken in several countries, including the United States (6 studies),
New Zealand (2 studies), China (2 studies), and the United Kingdom,
Iran, Germany, Chile, and Finland (1 study each) (Table 2).
Duration and intervention (dairy and exercise and PA)
Study durations ranged from 3wk to 3 y; speciﬁcally, from 3 to 16 wk
in 4 studies, from 1 to 2 y in 8 studies, and.2.5 y in 3 studies. Twelve
studies only used an intervention period (3 wk to 2 y), whereas the
remaining 3 studies also included a follow-up period (from 1 to 2.5 y)
(Table 2).
The dairy intervention involved the intake of milk in various
quantities or servings in most of the studies. As shown in Table
1, 9 studies (5, 10, 16–20, 22, 24) used only milk as the dairy pro-
duct in their interventions. The milk diﬀered in terms of percent-
age of fat (from 0%-fat to full-fat milk) and in the daily amount
required to be consumed (from 236 to 900 mL). However, in 2
of these studies (17, 18), the intervention involved milk powder
(enriched with calcium) of diﬀerent amounts [80 g in one study
(17) and either 40 or 80 g in another study (18)]. The rest of the
studies (6, 7, 15, 21, 23, 25) used other dairy products (i.e., yogurt
and cheese) along with milk in their intervention. With the excep-
tion of 2 studies (18, 25), all of other studies reported participants’
dietary calcium intake being between 650 (19) and 2076 (17) mg/d
and, on average, 1330 mg/d with the dairy intervention. The study
by Volek et al. (20) was the only study in which 12 wk of milk con-
sumption (3 servings/d, 708 mL 1%-fat milk, 1723 mg Ca/d) was
combined with resistance training (1 h 3 3 times/wk).
Measurement variables
Four main variables were measured in the 15 studies reviewed (Ta-
ble 1), including the following: 1) body size (height, sitting height,
weight, waist and hip circumference ratio, and BMI); 2) body com-
position (mainly LBM and FM) assessed by DXA in 9 studies (5–7,
15, 17, 18, 20, 22, 25), MRI in 1 study (24), and bioelectrical impend-
ence analysis in 1 study (21); 3) bone properties, mainly BMC and
BMD of the total body and of diﬀerent body sites, assessed by
DXA in 9 studies (5–7, 17–20, 22, 25); peripheral quantitative com-
puted tomography along with DXA in 1 study (25); and single- or
dual-photon absorptiometry in 2 studies (10, 23); and 4) biochemi-
cal markers (hormones, BTMs).
Main findings
From the 14 studies (5–7, 10, 15–25) that assessed body size, only 2
found signiﬁcant eﬀects (P, 0.05). Speciﬁcally, Du et al. (19) found
a signiﬁcant increase (P, 0.05) in height, sitting height, and weight
in Chinese 10-y-old girls after 2 y of a dairy intervention. In contrast,
Albala et al. (22) examined the eﬀects of a 16-wk dairy intervention
in 8- to 10-y-old overweight or obese boys and girls in Chile and
found a signiﬁcant increase in height for boys only. The same study
by Albala et al. (22) was the only one from the 11 studies that also
assessed body composition (5–7, 15, 17, 18, 20–22, 24, 25) that found
a signiﬁcant increase in LBM in both boys and girls (Table 2). In fact,
this study was the only study out of the 3 studies (16, 21, 24) that ex-
amined the eﬀects of dairy on body size and composition in over-
weight or obese boys and girls that found signiﬁcant eﬀects (Table 2).
From the 11 studies (5–7, 10, 17–20, 22, 23, 25) that assessed
bone mainly in normal-weight boys and girls, 8 (5–7, 18–20, 23,
25) reported signiﬁcant positive eﬀects on BMD and BMC for total
body or speciﬁc body sites (e.g., lumbar spine). Five of these stud-
ies (5, 19, 20, 23, 25) showed a signiﬁcant increase in total body
BMD ranging from 2.5% (after a 12-wk intervention with dairy
and three 1-h resistance exercise sessions/wk) (20) to 13.4% (after
a 1-y intervention) (23). Furthermore, the other 2 of these 5 studies
with an 18-mo intervention (5) and a 2-y intervention (25) found
changes of 9.6% and 10.4% in total body BMD, respectively,
whereas 1 study with a 2-y intervention (19) found a 3.2% increase
in BMD after adjusting for size.
Biochemical markers, including hormones [e.g., parathyroid
hormone (PTH), 25-hydroxyvitamin D]; BTMs, including markers
of bone formation (e.g., osteocalcin and bone-speciﬁc alkaline
phosphatase) and bone resorption markers (e.g., urinary calcium
to creatinine ratio); and in a few cases, inﬂammatory markers
(C-reactive protein, leptin) were assessed in 8 studies (5–7, 19,
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21, 23–25) (Table 1). Speciﬁcally, BTMs were assessed in 6 studies
(5–7, 19, 23, 25), which showed nonsigniﬁcant results in 4 studies
(5, 6, 23, 25) and some signiﬁcant changes in only 2 studies (7, 19).
Nonsigniﬁcant eﬀects were also reported for the other biochemi-
cal markers, with the exception of a signiﬁcant increase in insulin-
like growth factor I (IGF-I) in the dairy group, which was found
in 1 study (5).
Discussion
This review examined the outcomes of dairy consumption interven-
tions in children and adolescents. Overall, the ﬁndings suggest
positive eﬀects of dairy consumption on bone properties, with 8
of the 11 studies showing signiﬁcant increases in BMC and BMD
(total body and diﬀerent sites). Speciﬁcally, the combined results
of 5 of these studies showed an average increase of ;8% in
BMD after an average 16 mo of dairy consumption (milk, yogurt,
or cheese), with calcium intakes of ;1000 mg/d. These 5 studies
assessed BMD in boys and girls aged 10–17 y old, who were mainly
of normal weight and health status and from diﬀerent countries
(e.g., the United States, the United Kingdom, and China). Some
of these studies were included in previous reviews by Lanou
et al. (9) and Huncharek et al. (12).
The positive eﬀects of dairy consumption on bone-related var-
iables (BMD and BMC) can be attributed to signiﬁcant increases in
dietary calcium intake, with the latter being signiﬁcantly higher in
the dairy group than in the control group in most of the included
studies. For example, in the study by Chan et al. (6), the control
group had a daily calcium intake of 728 mg compared with 1461 mg
in the dairy group. However, signiﬁcant treatment eﬀects were also
reported by Cheng et al. (25), although there was a nonsigniﬁcant
diﬀerence in dietary calcium intake between the dairy (cheese) group
and the calcium-supplement (calcium carbonate tablets) group. Thus,
the positive eﬀects of dairy product consumption on bone might be
better explained by the improved absorption of calcium from dairy
due to the presence of lactose, casein phosphopeptides, or vitamin
D in dairy products (33).
There are various nutritional components found in dairy pro-
ducts that can aﬀect bone structure and physiology. For example,
calcium and protein can aﬀect bone mineralization (through the
formation of hydroxyapatite crystals) and collagen formation, re-
spectively (34). According to a review by Tang et al. (35), experi-
mental and observational studies have shown beneﬁcial eﬀects of
high protein intake on bone health and an increased risk of frac-
ture with inadequate protein intake. In addition, the high calcium
and vitamin D intakes achieved via dairy products can lead to de-
creased circulating PTH, decreased bone turnover, and increased
bone mass (34). Speciﬁcally, PTH increases when blood calcium
concentrations are low (i.e., due to low dietary calcium). This
causes calcium to be released from the bones, leading to bone re-
sorption and eventually a reduction in BMD. The latter has been
negatively correlated with the concentrations of serum PTH in ad-
olescent males and females in the RCT by Renner et al. (23), who
examined the eﬀects of calcium intake through milk and milk
products on BMD.
It is noteworthy that 4 of the studies (5, 6, 19, 25) that reported
signiﬁcant eﬀects of dairy consumption on BMC and BMD did not
also show signiﬁcant eﬀects on BTMs. One reason for this may re-
late to the relatively long duration (.1 y) of these RCTs. BTMs can
respond to treatment more quickly than BMD, so these can be bet-
ter used in clinical trials that measure acute and shorter-term ef-
fects (,6 mo) of diﬀerent treatment modalities such as diet and
exercise (36–38). Another possible reason may be the relative dif-
ﬁculty in evaluating the magnitudes of changes in BTMs, because
they are aﬀected by a variety of factors such as puberty, growth,
hormones, nutrition, exercise, circadian rhythm, and sensitivity
and speciﬁcity of assays (39).
In relation to body size and composition, there are few possible
mechanisms through which the consumption of dairy products may
have positive eﬀects. First, a calcium and vitamin D interaction can
aﬀect adipocyte lipogenesis and lipolysis, as well as fat oxidation
(40–42). Second, calcium can help decrease fat absorption and in-
crease fat excretion (43). Third, calcium can help regulate appetite
and food-fat intake (44). A fourth mechanism may be related to
the beneﬁcial eﬀects of various nutritional components found in
dairy products such as BCAAs (45) and medium-chain TGs (46).
Despite the aforementioned mechanisms, dairy consumption
did not show signiﬁcant eﬀects on body size and composition in
most of the included RCTs. Speciﬁcally, only 2 (19, 22) of the 14
studies showed signiﬁcant eﬀects on height and weight, and
only 1 (22) of the 11 studies that examined body composition found
a signiﬁcant increase in LBM. Speciﬁcally, Albala et al. (22), who
examined the eﬀects of replacing the habitual consumption of
sugar-sweetened beverages with milk for 16 wk in Chilean over-
weight or obese boys and girls, could not show signiﬁcant eﬀects
in body fat despite the signiﬁcant increase in LBM. According to
the authors, either the short duration of the intervention or the re-
placement of one energy-containing beverage for another that af-
fected the energy reduction in participants’ diets was the reason
for not showing signiﬁcant eﬀects on body fat.
Certain design and methodologic limitations of the included
studies (Table 2) can explain, in part, why most of the eﬀects, es-
pecially on body size and composition, were not signiﬁcant. Some
of these limitations have been previously mentioned (1–3). For ex-
ample, most of the RCTs did not estimate sample size nor did they
consider the experimental power required for detecting a signiﬁ-
cant eﬀect. Thus, their sample size was relatively small, which
possibly explains the nonsigniﬁcant ﬁndings.
As previously mentioned by Huang and McCrory (2), the lack
of compliance monitoring in the RCTs may be another important
reason for not ﬁnding signiﬁcant eﬀects. Most of the included
studies did not report their participants’ compliance with the
dairy intervention. On the other hand, compliance was relatively
high (.80%) in the few studies in which compliance was reported
(e.g., 99% and 100% in studies 8 and 9, respectively). The assess-
ment of dietary intake by using self-report methods, such as food
records or recall, is another methodologic weakness, which was
highlighted as a potential reason for not ﬁnding signiﬁcant eﬀects
on FM in 3 studies (15, 21, 22).
The potential confounding eﬀects of decisive factors such as
energy intake, PA, and puberty were not addressed in most of
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the relevant studies and, as mentioned in previous reviews, may
have aﬀected the ﬁndings (2, 4, 13). For example, except for the
study by Lappe et al. (15), energy intake was not statistically con-
trolled for in all of the other RCTs, and this might have obscured
the eﬀects of dairy on body composition. In addition, healthy eat-
ing or energy restriction was not necessarily recommended and
not followed by participants in any of these RCTs that assessed
the eﬀects of dairy consumption on body composition. As a result,
this may be the main reason for not ﬁnding signiﬁcant eﬀects of
increased dairy consumption on body composition. In keeping
with this trend, Weaver et al. (16) suggested that areas of future
research should include energy-reducing diets along with an in-
creased dairy intake to adequately assess these eﬀects. Other con-
founding factors, such as sex, puberty, and PA level, were
controlled for in 7 studies (5, 15, 18, 19, 22, 24, 25), but not in all
of the RCTs, which adds to the limited acceptability of the com-
posite results.
Even though most of the included studies scored quite well on
the Jadad scale, future RCTs should address these methodologic
limitations in order to clarify both the statistical and the substan-
tive signiﬁcance of the ﬁndings. On the other hand, there is poten-
tial to improve the intervention models. For example, it has been
previously suggested (16) that dietary interventions of higher cal-
cium intake combined with energy restriction should be used in
future RCTs, especially in overweight or obese participants.
Thus, dairy consumption should be combined with healthy eating
advice as well as exercise in order to achieve a modest energy def-
icit or a stimulus for body composition change in a pediatric pop-
ulation. Indeed, exercise should be included in any intervention
that assesses the eﬀects of dairy consumption on bone, as, for ex-
ample, in one of the included studies by Volek et al. (20). As men-
tioned above, this study with a 12-wk dairy intervention (3 servings
milk/d) combined with resistance exercise (3 times/wk) found
signiﬁcant eﬀects on total body BMD, even in a relatively short pe-
riod of time.
The present systematic review has 2 distinct advantages com-
pared with previous relevant reviews: the exclusive use of RCTs
and the use of a standardized tool (Jadad scale) for the assessment
of the methodologic quality of the included studies. The Jadad
scale has shown the best validity and reliability among other rele-
vant scales that assess RCTs in health research (47). In addition,
most of the methodologic and statistical criteria used in this re-
view were in accordance with the criteria proposed in AMSTAR,
a reliable and valid tool for assessing the quality of systematic re-
views (48, 49). On the basis of the 11 questions of this tool, the cur-
rent systematic review had a score of 6, which is satisfactory
considering that 30 randomly selected systematic reviews had
scores between 3 and 10 (49). However, the present systematic re-
view also has limitations. Our search was limited to 2 databases
and included only studies published in English. Therefore, future
systematic reviews on this topic may extend their search to more
databases and potentially to other languages.
The signiﬁcance of this review relates to the importance of pro-
viding solid evidence on the role of dairy consumption on body
size, body composition, and bone properties in children and ado-
lescents. In conclusion, it appears that dairy consumption has
overall positive eﬀects on bone structure and development in chil-
dren and adolescents, but there is not enough evidence to support
the beneﬁcial role of dairy consumption on body size and compo-
sition in this population. Further research (mainly RCTs) that
overcomes the above limitations is needed to provide clear evi-
dence on this critical issue.
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